| ARTEMIS US SELECT I ACC GBP | RVI USA | 31,66% | · | · | · |
| ARTEMIS US SELECT I INC GBP | RVI USA | 31,66% | · | · | · |
| CARMIGNAC PORTFOLIO EMERGENTS F CHF ACC HDG | RVI EMERGENTES | 31,66% | 66,39% | 56,82% | 156,68% |
| VONTOBEL FUND-MTX ASIAN LEADERS (EX JAPAN) I EUR CAP | RVI ASIA EX-JAPÓN | 31,66% | 76,15% | 50,73% | · |
| AMUNDI MSCI EMERGING MARKETS ESG BROAD TRANSITION UCITS ETF DR CAP | RVI EMERGENTES | 31,65% | 78,37% | 53,49% | · |
| JPM THEMATICS-GENETIC THERAPIES I2 (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 31,65% | 37,90% | -19,36% | · |
| NINETY ONE GSF GLOBAL NATURAL RESOURCES FUND A INC USD | RVI MATERIAS PRIMAS | 31,65% | 53,26% | 109,91% | 195,21% |
| NOMURA FUNDS IRELAND - JAPAN STRATEGIC VALUE FUND R USD HEDGED | RVI JAPÓN VALOR | 31,65% | 95,69% | 176,77% | 210,19% |
| UBS MSCI JAPAN INDEX FUND USD I-B ACC | RVI JAPÓN | 31,65% | 66,89% | · | · |
| ISHARES JAPAN EQUITY INDEX FUND (LU) A2 USD CAP | RVI JAPÓN | 31,64% | 64,03% | 60,17% | 126,72% |
| AMUNDI PRIME JAPAN UCITS ETF DR CAP | RVI JAPÓN | 31,63% | 66,81% | 66,48% | · |
| FRANKLIN TECHNOLOGY A (ACC) SGD-H1 | RVI TECNOLOGÍA | 31,63% | 114,01% | 70,49% | · |
| AMUNDI FUNDS EMERGING WORLD EQUITY R2 EUR (C) | RVI EMERGENTES | 31,62% | 70,75% | 50,77% | · |
| LO FUNDS - TARGETNETZERO EMERGING MARKETS EQUITY SEED (EUR) R CAP | RVI EMERGENTES | 31,62% | 72,51% | 6,67% | -4,07% |
| SCHRODER ISF ASIAN EQUITY YIELD A ACC EUR | RVI ASIA EX-JAPÓN VALOR | 31,62% | 76,16% | 70,39% | 133,90% |
| AMUNDI CORE MSCI EMERGING MARKETS I13U CAP | RVI EMERGENTES | 31,61% | 76,99% | 56,12% | · |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 31,61% | 37,75% | -19,51% | · |
| POLAR CAPITAL BIOTECHNOLOGY S USD DIS | RVI BIOTECNOLOGÍA | 31,61% | 90,87% | 82,87% | 331,14% |
| MAN UMBRELLA SICAV - MAN AHL TREND ALTERNATIVE DNY H SEK ACC | RENT. ABSOLUTA. VOLAT. ALTA | 31,60% | 11,93% | 7,33% | · |
| SCHRODER ISF JAPANESE OPPORTUNITIES A ACC USD | RVI JAPÓN VALOR | 31,60% | 60,64% | 70,43% | 117,48% |
